Evaluation effect of treatment with IM D3 on clinical, paraclinical symptoms and signs and inhospital outcome at patient admitted with coovid19

Phase 1

• Conditions: COIVD-19 patient.; covid-19, virus identified; U07.1

• Registration Number: IRCT20200411047024N1
• Lead Sponsor: Shahroud University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Individual satisfaction to participate in the project
Confirmation of covid-19 disease by CPR test

Exclusion Criteria

Vitamin D levels are more than 30 Nanograms /milliliter

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical course. Timepoint: Before the intervention and two weeks after the intervention. Method of measurement: By recording information about the variables defined from the patients' hospital records.;Paraclinical. Timepoint: Before the intervention and two weeks after the intervention. Method of measurement: Registration of patient's laboratory information and CT scan.;Outcome. Timepoint: Before the intervention and two weeks after the intervention. Method of measurement: Doctor's approval and death certificate.

Secondary Outcome Measures

Name	Time	Method
Duration of hospitalization. Timepoint: End of hospitalization. Method of measurement: Hospital file.;Severe chest pain. Timepoint: Before the intervention and two weeks after the intervention. Method of measurement: Ask the patient.;Severe shortness of breath. Timepoint: Before the intervention and two weeks after the intervention. Method of measurement: Ask the patient.;How many days after hospitalization they died. Timepoint: End of hospitalization. Method of measurement: ask the patient.